TVTX

Q: What is the price of Travere Therapeutics (TVTX) today?

The price of Travere Therapeutics (TVTX) today is $ 34.83, with return of 101.1% compared to the last year. The price of Travere Therapeutics (TVTX) started the year trading around $ 17.42 and today it is at $ 34.83. Follow the real-time price chart, the historical price of Travere Therapeutics (TVTX) and international markets.

Q: When does Travere Therapeutics (TVTX) pay dividends?

Travere Therapeutics (TVTX) did not distribute dividends in the last year.

Q: Is Travere Therapeutics (TVTX) worth it?

Currently, Travere Therapeutics (TVTX) is priced at $ 34.83, with a P/E of -35.18%, representing a deviation of -1,220% from its historical average P/E. In the last year, the stock showed a variation of 101.1 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 101.10%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Travere Therapeutics (TVTX) stock?

Investing in stocks of Travere Therapeutics (TVTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Travere Therapeutics (TVTX) yield today?

The yield of Travere Therapeutics (TVTX) was 2.77% in the last month, 101.10% in the last year and 33.65% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Travere Therapeutics (TVTX) today, the total investment would be $ 3,483.00, based on the current price of $ 34.83.If past performance were to repeat, the return on your investment would be:In 1 year: $ 7,004.31In 5 years: $ 4,655.03In 10 years: $ 5,793.27It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Travere Therapeutics Inc.

Price

$ 34.83

return (12m)

101.10%

p/e

-35.18

p/bv

42.35

DIVIDEND YIELD

0.00%

price TVTX

TVTX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of TVTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.77%

3 months

48.40%

1 year

101.10%

2 years

303.59%

5 years

33.65%

10 years

66.33%

Fundamentals TVTX

review the fundamentals of Travere Therapeutics shares

P/E

-35.18

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

7.15

Sector: -3.71 Industry: -3.71

P/BV

42.35

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-16.44%

Sector: -63.91% Industry: -63.91%

ROE

-120.36%

Sector: -67.36% Industry: -67.36%

ROIC

40.58%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

-20.32%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

97.63%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

-20.59%

Sector: -41.51% Industry: -41.51%

P/EBITDA

-89.85

Sector: -3.78 Industry: -3.78

P/EBIT

-40.31

Sector: -3.91 Industry: -3.91

P/ASSET

5.78

Sector: 1.49 Industry: 1.49

BVPS

0.83

Sector: 1.73 Industry: 1.73

EPS

-0.99

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.14

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

17.05%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-12.17%

Sector: - Industry: -

Fundamentals TVTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	15.06	1.59	10.56%	6.61%	$ 147.98 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	13.80	7.96	57.70%	3.53%	$ 212.69 B	32.78%
MRK	13.09	0.00	0.00%	3.25%	$ 249.10 B	29.63%
AZN	29.76	6.09	20.45%	1.74%	$ 279.74 B	16.17%
BMY	17.58	5.71	32.47%	4.76%	$ 106.18 B	12.57%
GILD	18.58	7.02	37.80%	2.59%	$ 150.68 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.56 B	28.21%
HALO	12.44	14.70	118.17%	0.00%	$ 7.41 B	47.91%
REGN	16.32	2.41	14.79%	0.49%	$ 74.71 B	32.13%
AMGN	25.34	18.45	72.82%	2.85%	$ 177.48 B	19.47%
VRTX	31.73	6.73	21.22%	0.00%	$ 116.60 B	31.35%
MCK	24.84	-173.31	-697.75%	0.37%	$ 100.18 B	1.04%
CAH	29.67	-17.33	-58.40%	1.02%	$ 47.32 B	0.68%
ADMA	22.65	11.00	48.57%	0.00%	$ 4.74 B	42.87%
BIIB	16.57	1.46	8.83%	0.00%	$ 26.65 B	15.98%
HRMY	12.44	2.77	22.24%	0.00%	$ 2.31 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TVTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Travere Therapeutics

Travere Therapeutics Inc.

Average user rating I10

4.0 (0 people)

United States

14 years

Founded: 2011

2003

Time since IPO - 22 years

262

Employees

The Company Travere Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 3.12 Billions, having an equity of $ 73.56 Millions.

With a total of 262 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 435.83 Millions, which generated a profit in the amount of $ -88.54 Millions.

As for its main indicators, the Company has a P/E ratio of -35.18, a P/BV ratio of 42.35 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TVTX.

Market cap

$ 3.12 Billions

Net worth

$ 73.56 Millions

US$ 73,560,000.00

Assets

$ 538.58 Millions

US$ 538,580,000.00

Total Shares Outstanding

89.00 Millions

89,000,000

Average Daily Trading Volume

$ 1.86 Million

US$ 1,860,098.90

Sector

Health Care

Industry

Biotechnology

TVTX

TVTX revenue and profits

Financial Results TVTX

DRAG THE FRAME TO SEE MORE DATA

TVTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

24.84

0.37%

ROE

-697.75%

P/BV

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.67

1.02%

ROE

-58.40%

P/BV

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.09

3.25%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

15.06

6.61%

ROE

10.56%

P/BV

1.59

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.76

1.74%

ROE

20.45%

P/BV

6.09

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

24.84

0.37%

ROE

-697.75%

P/VP

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.67

1.02%

ROE

-58.40%

P/VP

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.09

3.25%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

15.06

6.61%

ROE

10.56%

P/VP

1.59

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.76

1.74%

ROE

20.45%

P/VP

6.09

Frequently Asked Questions

What is the price of Travere Therapeutics (TVTX) today?

The price of Travere Therapeutics (TVTX) today is $ 34.83, with return of 101.1% compared to the last year. The price of Travere Therapeutics (TVTX) started the year trading around $ 17.42 and today it is at $ 34.83. Follow the real-time price chart, the historical price of Travere Therapeutics (TVTX) and international markets.

When does Travere Therapeutics (TVTX) pay dividends?

Travere Therapeutics (TVTX) did not distribute dividends in the last year.

Is Travere Therapeutics (TVTX) worth it?

Currently, Travere Therapeutics (TVTX) is priced at $ 34.83, with a P/E of -35.18%, representing a deviation of -1,220% from its historical average P/E. In the last year, the stock showed a variation of 101.1 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 101.10%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Travere Therapeutics (TVTX) stock?

Investing in stocks of Travere Therapeutics (TVTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Travere Therapeutics (TVTX) yield today?

The yield of Travere Therapeutics (TVTX) was 2.77% in the last month, 101.10% in the last year and 33.65% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Travere Therapeutics (TVTX) today, the total investment would be $ 3,483.00, based on the current price of $ 34.83.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 7,004.31
In 5 years: $ 4,655.03
In 10 years: $ 5,793.27

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TVTX

Travere Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of TVTX

review the fundamentals of Travere Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Travere Therapeutics

Travere Therapeutics Inc.

United States

14 years

2003

262

PROFIT X PRICE TVTX

Financial Results TVTX

TVTX cash flow

asset growth - TVTX

TVTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions